Emerald Advisers’s Aehr Test Systems AEHR Stock Holding History

Emerald Advisers’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16M	Buy	+161,085	New	+$14.8M	0.44%	94

Other funds holding AEHR

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Premier Fund Managers Guildford, United Kingdom $978M AUM 14.27% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.6B AUM 38.62% 1-Year Est. Return

Emerald Advisers's AEHR Position: Q3 2026 in Review

Emerald Advisers opened a new position in Aehr Test Systems (AEHR) in Q3 2026: 161,085 shares worth $16M. The stake represents 0.44% of the portfolio and ranks #94 among its holdings.

121 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.

Emerald Advisers held 161,085 shares of Aehr Test Systems worth $16M as of Q3 2026.
Aehr Test Systems was a new Emerald Advisers position in Q3 2026.
Aehr Test Systems made up 0.44% of Emerald Advisers's portfolio in Q3 2026, its #94 holding.
121 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.

Based on Emerald Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.